全文获取类型
收费全文 | 1140篇 |
免费 | 61篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 119篇 |
妇产科学 | 16篇 |
基础医学 | 92篇 |
口腔科学 | 36篇 |
临床医学 | 184篇 |
内科学 | 247篇 |
皮肤病学 | 17篇 |
神经病学 | 21篇 |
特种医学 | 216篇 |
外科学 | 79篇 |
综合类 | 37篇 |
预防医学 | 51篇 |
眼科学 | 19篇 |
药学 | 39篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 35篇 |
出版年
2022年 | 8篇 |
2021年 | 8篇 |
2020年 | 14篇 |
2019年 | 9篇 |
2018年 | 15篇 |
2017年 | 18篇 |
2016年 | 10篇 |
2015年 | 22篇 |
2014年 | 24篇 |
2013年 | 22篇 |
2012年 | 22篇 |
2011年 | 21篇 |
2010年 | 41篇 |
2009年 | 46篇 |
2008年 | 26篇 |
2007年 | 10篇 |
2006年 | 16篇 |
2005年 | 16篇 |
2004年 | 15篇 |
2003年 | 16篇 |
2002年 | 20篇 |
2001年 | 16篇 |
2000年 | 12篇 |
1999年 | 22篇 |
1998年 | 83篇 |
1997年 | 84篇 |
1996年 | 89篇 |
1995年 | 58篇 |
1994年 | 53篇 |
1993年 | 45篇 |
1992年 | 21篇 |
1991年 | 23篇 |
1990年 | 11篇 |
1989年 | 37篇 |
1988年 | 30篇 |
1987年 | 41篇 |
1986年 | 19篇 |
1985年 | 30篇 |
1984年 | 23篇 |
1983年 | 20篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1969年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有1213条查询结果,搜索用时 15 毫秒
1.
Purnima Gogoi Geetika Kaur Nikhlesh K Singh 《World journal of gastroenterology : WJG》2022,28(46):6497-6511
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer-related mortality in the United States. Across the globe, people in the age group older than 50 are at a higher risk of CRC. Genetic and environmental risk factors play a significant role in the development of CRC. If detected early, CRC is preventable and treatable. Currently, available screening methods and therapies for CRC treatment reduce the incidence rate among the population, but the micrometastasis of cancer may lead to recurrence. Therefore, the challenge is to develop an alternative therapy to overcome this complication. Nanotechnology plays a vital role in cancer treatment and offers targeted chemotherapies directly and selectively to cancer cells, with enhanced therapeutic efficacy. Additionally, nanotechnology elevates the chances of patient survival in comparison to traditional chemotherapies. The potential of nanoparticles includes that they may be used simultaneously for diagnosis and treatment. These exciting properties of nanoparticles have enticed researchers worldwide to unveil their use in early CRC detection and as effective treatment. This review discusses contemporary methods of CRC screening and therapies for CRC treatment, while the primary focus is on the theranostic approach of nanotechnology in CRC treatment and its prospects. In addition, this review aims to provide knowledge on the advancement of nanotechnology in CRC and as a starting point for researchers to think about new therapeutic approaches using nanotechnology. 相似文献
2.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
3.
National Programme of Research in Human Reproduction S.K. Banerjee R. Baveja R.V. Bhatt A. Chatterjee S.D. Choudhury B. Coyaji A.D. Engineer M.P. Gogoi V. Hingorani K. Lal M. Kochhar U. Krishna P. Misra F.S. Philips R. Rajan P.C. Sen Gupta K. Zaveri S. Datey S. Gupta S. Mehta N.C. Saxena B.N. Saxena 《Contraception》1986,34(6):573-582
The return of fertility following discontinuation of norethisterone oenanthate (NET EN) 200 mg injectable contraceptive after use for a minimum period of six months or more was studied in 69 women who discontinued the method for planning pregnancy. Former users of copper intra-uterine device (CuT 200) were enrolled as a control group. Another 161 women who had discontinued NET EN due to other reasons (e.g. amenorrhoea, excessive bleeding or personal reasons) were also studied for return of fertility after ensuring that they were not using any other method of contraception and were exposed to the risk of pregnancy. The subjects from both groups were followed for a period of one year. The cumulative conception rates at one year were 72.5 and 83.6 per 100 subjects for ex-NET EN and ex-CuT 200 users who had discontinued the method for planning pregnancy and this difference was not statistically significant (P > 0.05). The median time for conception for ex-NET EN users was 7.8 months as compared to 3.7 months in ex-CuT 200 users but the cumulative conception rates at the end of one year show that future return of fertility in NET EN users does not appear to be adversely affected.
In 51 subjects who had discontinued NET EN due to amenorrhoea, the return of fertility was predictably slower and less. The return of fertility in subjects who discontinued NET EN for other reasons (e.g. excessive bleeding and other personal reasons) was similar to ex-NET EN and ex-CuT 200 users. 相似文献
4.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献5.
6.
7.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
8.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献
9.
10.